Showing 171-180 of 6590 results for "".
Physician Spotlight: Steven Hacker, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-hacker-md/20915/Insights from a medical entrepreneur.Andrew F. Alexis, MD, MPH
https://practicaldermatology.com/topics/general-topics/andrew-f-alexis-md-mph/21369/Physician Spotlight: Desiree Ratner, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-desiree-ratner-md/20505/Winning the war on non-melanoma skin cancer.Benchside Dispatches: Pruritus
https://practicaldermatology.com/topics/practice-management/benchside-dispatches-pruritus/20926/An interview with Gil Yosipovitch, MDHow to Discuss Isotretinoin’s Safety Profile With Acne Patients
https://practicaldermatology.com/conferences/maui-derm-2024/how-to-discuss-isotretinoins-safety-profile-with-acne-patients/20237/Acne Symposium moderator Guy Webster, MD, PhD, clinical professor of dermatology at Thomas Jefferson University, explains how he helps adolescent patients with the most severe cases of acne manage the potential side effects of isotretinoin.Atopic Dermatitis: Rethinking the “Typical” Patient
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-rethinking-the-typical-patient/19666/It's possible to make generalities about the experience of atopic dermatitis, but it's increasingly clear that there is no "typical" patient. Zelma Chiesa Fuxench, MD discusses the latest findings on the signs and symptoms of AD and the populations affected.Managing Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Guselkumab in PsA: Exploring Patient-Reported Outcomes in Real-World Settings
https://practicaldermatology.com/topics/psoriasis/guselkumab-in-psa-exploring-patient-reported-outcomes-in-real-world-settings/20226/Philip Mease, MD, shares new real-world data showing that psoriatic arthritis patients who take Tremfya (guselkumab) report meaningful improvements in pain, physical function, and fatigue through six months.Using GEP Test Results to Manage Patients
https://practicaldermatology.com/programs/practical-dermatology-updates-in-skin-cancer/using-gep-test-results-to-manage-patients/35603/Jason M. Rizzo, MD, describes how gene expression profile (GEP) testing works and how the results can be used to manage patients from a dermatologist's perspective.SDPA: Dr. Matthew Zirwas Shares Passion for Treating Atopic Dermatitis
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-dr-matthew-zirwas-shares-passion-for-treating-atopic-dermatitis/29509/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Matthew Zirwas, MD. He provides a passionate overview of his lecture on atopic dermatitis, itch, and contact dermatitis.